Please login to the form below

Not currently logged in
Email:
Password:

Intellectual property

This page shows the latest Intellectual property news and features for those working in and with pharma, biotech and healthcare.

Redmile and Google help Evox raise £35.5m for exosome pipeline

Redmile and Google help Evox raise £35.5m for exosome pipeline

We have also vigorously expanded our robust intellectual property portfolio, built our internal R&D teams, and put in place advisory boards who are offering deep insights as we advance key

Latest news

More from news
Approximately 4 fully matching, plus 285 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 30 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

  • Random42 appoints Bill Collis as Chairman

    He has vast experience in venture capital and private equity funding, intellectual property licensing, mergers and acquisitions and accessing international markets.

  • Management Forum Ltd

    Pharmaceutical, Animal Health, Medical Devices, Legal and Intellectual Property professionals around the world.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...
Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...

Infographics